Investors
QUALIblood is a Belgian Contract Research Organization created in 2017 and proposing classical and innovative bioanalysis services.
Always looking to propose the best solutions to the customers, the team is contiuously working on the development of new analyses and biomarkers internally or through collaborations with keys actors in the health sectors (biotech, pharma, hospitals, universities).
QUALIblood has received over the last five years important support from the Walloon Region in Grants and Non-Dilutive Fundings. These funds have supported the development of the Company’s technological innovations such as nAPCsr and researches.
